Ionising radiation can be life-threatening to humans. It can, however, also help to save lives in tumour therapy, for example. The use of heavy ions, in particular, is very successful in this respect. These ions cause genetic changes, thus preventing tumour cells from continuing to grow while the surrounding tissue remains, to a large extent, untouched. It is not entirely understood precisely how ionising radiation, and in particular, heavy ions, function. The main aim of RTG1657 "Molecular and Cellular Responses to Ionising Radiation", therefore, is to investigate and clarify the mechanisms of action of ionising radiation from the molecular level to that of cellular reaction, as well as of the radiation response on the organism as a whole. To this end, the RTG will combine new research approaches in cell and molecular biology as well as in bioinformatics.
(Coordinating university: Darmstadt University of Technology; Coordinator: Professor Dr. Markus Lbrich)
The discovery of iron-arsenic compounds as a new class of high-temperature superconductors in 2008 has led to a renewed enthusiasm for superconductivity research, one resembling the activity accompanying the initial research into high-temperature superconductors 20 years ago. The aim of RTG 1621 "Itinerant Magnetism and Superconductivity in Intermetallic Compounds" is to investigate what are known as iron pnictides and related intermetallic superconductors. The RTG's main goal is to pinpoint the previously unexplained mechanism of superconductivity in these compounds as well
|Contact: Marco Finetti|